abstract |
The invention relates to oligoribonucleotides, which are capable of inducing the breakdown of the mRNA of enzymes that breakdown connective tissue, and to pharmaceutical and cosmetic compositions, which are provided for topical application and which contain said oligoribonucleotides. The compositions are particularly suited for treating degenerative skin disorders. |